1132088-63-1

1132088-63-1 structure

1132088-63-1 structure

Name: Valganciclovir-d8 hydrochloride
Chemical Name: Valganciclovir-d8
CAS Number: 1132088-63-1
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Anti-infection CMV
Create Date: 2018-07-12 20:38:51
Modify Date: 2024-02-08 18:53:40
Valganciclovir-d8 (hydrochloride) is the deuterium labeled Valganciclovir hydrochloride[1]. Valganciclovir hydrochloride, the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir[2][3][4].

Name	Valganciclovir-d8

Description	Valganciclovir-d8 (hydrochloride) is the deuterium labeled Valganciclovir hydrochloride[1]. Valganciclovir hydrochloride, the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir[2][3][4].
Related Catalog	Signaling Pathways >> Anti-infection >> CMV
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Sugawara M, et al. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci. 2000 Jun;89(6):781-9. [3]. Chawla JS, et al. Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature. Transpl Infect Dis. 2012 Jun14(3):259-67. [4]. O'Brien S, et al. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood. 2008 Feb 15111(4):1816-9.

No Any Chemical & Physical Properties